Latest stories on RNAZ
TransCode Therapeutics Advances TTX-MC138 After Positive Phase 1a
TipRanks67 · bullishproduct/pr
TransCode Sets Key Deadlines for 2026 Shareholder Meeting
TipRanks50 · neutralgeneral
TransCode Therapeutics Initiates Phase 2a Clinical Trial with TTX-MC138 in Patients with ctDNA Positive Colorectal Cancer
PR Newswire58 · neutralproduct/pr
TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice
TipRanks33 · bearishgeneral